Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SINOVAC BIOTECH LTD.

(SVA)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Philippines seals deal for 40 mln Pfizer/BioNTech COVID-19 doses

06/20/2021 | 02:48am EDT

(Corrects timetable of delivery in second paragraph)

* Deliveries to begin 'after eight weeks starting August'

* Philippines has secured 113 mln doses from vaccine suppliers

* Government wants to vaccinate up to 70 million Filipinos

MANILA, June 20 (Reuters) - The Philippine government has signed a supply agreement for 40 million doses of the COVID-19 vaccine developed by Pfizer Inc and BioNTech SE in its biggest coronavirus vaccine deal to date.

Deliveries of the vaccine, among several brands of coronavirus shots allowed for emergency use in the Southeast Asian country, will begin in late September, Carlito Galvez, head of the government's COVID-19 vaccine procurement, said on Sunday.

The Philippines last week started a programme to vaccinate 35 million people working outside their homes, while continuing to inoculate priority sectors such as healthcare workers and elderly citizens, hoping to achieve herd immunity this year.

More than 8 million doses have been administered, of which about 6 million were for first dose, suggesting a slow vaccine rollout that puts the government's target to vaccinate up to 70 million people this year in doubt.

Vaccine supply around the capital Manila remains limited, while COVID-19 cases in several provinces have surged, complicating efforts to ramp up the immunisation drive in a country with some of Asia's largest numbers of infections and deaths.

With the latest deal, the Philippines has secured the delivery of 113 million doses from five vaccine manufacturers - also including China's Sinovac with 26 million doses, Russia's Sputnik V with 10 million doses, 20 million doses from Moderna and 17 million doses from AstraZeneca.

The ramp-up comes as Taiwan was expecting 2.5 million doses of the Moderna vaccine to arrive on Sunday from the United States, more than doubling the arsenal of the semiconductor-producing island as it deals with a rise in domestic infections.

The Philippines also expects vaccine deliveries from the international COVAX facility to reach 44 million doses, while 16 million doses of vaccines developed by Novavax and Johnson & Johnson were still under negotiation, Galvez said.

The new arrangement "will significantly boost our national immunisation programme and will enable us to realize our goal of achieving herd immunity by year-end," he said.

The Philippines will allow the Pfizer-BioNTech vaccine to be given to children aged 12 to 15, possibly starting later this year when the vaccine inventory will have increased and the inoculation of the priority sectors has been completed, he said.

(Reporting by Enrico Dela Cruz; Editing by William Mallard and Christopher Cushing)


ę Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC 0.16% 8266 Delayed Quote.12.68%
MODERNA, INC. 4.94% 345.53 Delayed Quote.214.44%
NOVAVAX, INC. 3.18% 184.74 Delayed Quote.60.53%
SINOVAC BIOTECH LTD. -0.31% 6.47 Delayed Quote.0.00%
All news about SINOVAC BIOTECH LTD.
07/27SINOVAC BIOTECH : Antibodies from Sinovac's COVID-19 shot fade after about 6 mon..
RE
07/26SINOVAC BIOTECH : Brazil says China's Sinopharm seeks COVID-19 vaccine emergency..
RE
07/26SINOVAC BIOTECH : Antibodies from Sinovac's COVID-19 shot fade after about 6 mon..
RE
07/24SINOVAC BIOTECH : Indonesia prepares more ICU units, waits to see if COVID curbs..
RE
07/23SINOVAC BIOTECH : China's Sinovac evaluates vaccine plant in Chile
RE
07/20SINOVAC BIOTECH : Receives Approval on Sabin Strain Based Inactivated Polio Vacc..
PU
07/20SINOVAC BIOTECH : CoronaVac Used on Child Population in China, Good Antibody Lev..
PU
07/20SINOVAC Biotech Ltd. Announces Use of CoronaVac, its COVID-19 Vaccine on Chil..
CI
07/19SINOVAC BIOTECH : Polio Vaccine Gets China's Medical Regulator OK
MT
07/19SINOVAC BIOTECH : Receives Approval on Sabin Strain Based Inactivated Polio Vacc..
BU
More news
Financials (USD)
Sales 2020 511 M - -
Net income 2020 110 M - -
Net cash 2020 1 040 M - -
P/E ratio 2020 6,66x
Yield 2020 -
Capitalization 642 M 642 M -
EV / Sales 2019 1,86x
EV / Sales 2020 -0,78x
Nbr of Employees 1 959
Free-Float 33,1%
Chart SINOVAC BIOTECH LTD.
Duration : Period :
Sinovac Biotech Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Wei Dong Yin Chairman, President, CEO, Secretary & MD
Nan Wang CFO & Vice President-Business Development
Qiang Gao Chief Operating Officer & Vice President
Yuk Lam Lo Independent Director
Jian Li Independent Director
Sector and Competitors
1st jan.Capi. (M$)
SINOVAC BIOTECH LTD.0.00%642
CSL LIMITED2.24%98 120
WUXI BIOLOGICS (CAYMAN) INC.15.86%58 749
SAMSUNG BIOLOGICS CO.,LTD.9.69%51 963
BIOGEN INC.35.56%49 771
ALEXION PHARMACEUTICALS, INC.0.00%40 336